FAKTOR-OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000SN3KGA2

Delayed Deutsche Boerse AG 07:24:02 03/06/2024 pm IST
19.21 EUR +6.31% Intraday chart for FAKTOR-OPTIONSSCHEIN - STRYKER CORP.
1 month-11.16%
3 months-40.62%
Date Price Change
03/24/03 19.21 +6.31%
31/24/31 18.07 -6.13%
30/24/30 19.25 -0.82%
29/24/29 19.41 +6.30%
28/24/28 18.26 +8.56%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 07:24 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SN3KGA
ISINDE000SN3KGA2
Date issued 17/06/2022
Strike 202.1 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 39.6
Lowest since issue 5.32
Spread 2.03
Spread %9.79%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus